Your search returned 2 results.

Results
	1.	Prospective randomized trial of 5 days azacitidine versus supportive care in patients with lower-risk myelodysplastic syndromes without 5q deletion and transfusion-dependent anemia. [electronic resource] by Sanchez-Garcia, Joaquin Falantes, Jose Medina Perez, Angeles Hernandez-Mohedo, Francisca Hermosin, Lourdes Torres-Sabariego, Angeles Bailen, Alicia Hernandez-Sanchez, Jesus M Solé Rodriguez, María Casaño, Francisco Javier Calderon, Cristina Labrador, Maria Vahí, Maria Serrano, Josefina Lumbreras, Eva Hernández-Rivas, Jesus Maria Producer: 20190111 In: Leukemia & lymphoma vol. 59 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Results of treatment with azacitidine in patients aged ≥ 75 years included in the Spanish Registry of Myelodysplastic Syndromes. [electronic resource] by Xicoy, Blanca Jiménez, María-José García, Olga Bargay, Joan Martínez-Robles, Violeta Brunet, Salut Arilla, María-Jesús Pérez de Oteyza, Jaime Andreu, Rafael Casaño, Francisco-Javier Cervero, Carlos-Javier Bailén, Alicia Díez, María González, Bernardo Vicente, Ana-Isabel Pedro, Carme Bernal, Teresa Luño, Elisa Cedena, María-Teresa Palomera, Luis Simiele, Adriana Calvo, José-Manuel Marco, Víctor Gómez, Eduardo Gómez, Marta Gallardo, David Muñoz, Juan de Paz, Raquel Grau, Javier Ribera, Josep-Maria Benlloch, Luis-Enrique Sanz, Guillermo Producer: 20150715 In: Leukemia & lymphoma vol. 55 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)